Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Hanzal

Showing results (41-50 of 54) with videos related to

Pageof 6
Sort By:
British Journal of Cancer|January 1, 1997
Serum M3/M21 in ovarian cancer patientsC Tempfer, L Hefler, G Haeusler, et al.
European Journal of Cancer (Oxford, England : 1990)|October 1, 1996
Prognostic value of immunohistochemically detected CD44 isoforms CD44v5, CD44v6 and CD44v7-8 in human breast cancerC Tempfer, A Lösch, H Heinzl, et al.
Gynecologic and Obstetric Investigation|January 12, 2000
Could we treat more unruptured ectopic pregnancies with intramuscular methotrexate?E Kucera, M Schindl, I Klem, et al.
British Journal of Cancer|May 6, 1998
The prognostic value of CD44 isoform expression in endometrial cancerC Tempfer, G Haeusler, A Kaider, et al.
Zentralblatt Fur Chirurgie|January 1, 1991
[The role of intestinal resection in primary surgery of ovarian carcinoma]J Miholic, H Kölbl, E Hanzal, et al.
Gynakologisch-Geburtshilfliche Rundschau|January 1, 1995
[Urethrovesical morphology in continent women in spinal anesthesia]E Hanzal, G Häusler, C Sam, et al.
Bone and Mineral|December 1, 1993
Direct evidence of a parathyroid related protein gradient between the mother and the newborn in humansD Thiébaud, S Janisch, H Koelbl, et al.
International Journal of Cancer|April 22, 1997
CD44 is an independent prognostic factor in early-stage cervical cancerP Speiser, C Wanner, C Tempfer, et al.
Anticancer Research|September 1, 1995
The influence of obesity on the disease-free survival in primary breast cancerA Obermair, C Kurz, E Hanzal, et al.
Anticancer Research|March 1, 1996
Influence of delayed diagnosis on established prognostic factors in endometrial cancerA Obermair, E Hanzal, I Schreiner-Frech, et al.
Pageof 6

Showing results (41-50 of 54) with videos related to

Sort By:
Pageof 6
British Journal of Cancer|January 1, 1997
Serum M3/M21 in ovarian cancer patientsC Tempfer, L Hefler, G Haeusler, et al.
European Journal of Cancer (Oxford, England : 1990)|October 1, 1996
Prognostic value of immunohistochemically detected CD44 isoforms CD44v5, CD44v6 and CD44v7-8 in human breast cancerC Tempfer, A Lösch, H Heinzl, et al.
Gynecologic and Obstetric Investigation|January 12, 2000
Could we treat more unruptured ectopic pregnancies with intramuscular methotrexate?E Kucera, M Schindl, I Klem, et al.
British Journal of Cancer|May 6, 1998
The prognostic value of CD44 isoform expression in endometrial cancerC Tempfer, G Haeusler, A Kaider, et al.
Zentralblatt Fur Chirurgie|January 1, 1991
[The role of intestinal resection in primary surgery of ovarian carcinoma]J Miholic, H Kölbl, E Hanzal, et al.
Gynakologisch-Geburtshilfliche Rundschau|January 1, 1995
[Urethrovesical morphology in continent women in spinal anesthesia]E Hanzal, G Häusler, C Sam, et al.
Bone and Mineral|December 1, 1993
Direct evidence of a parathyroid related protein gradient between the mother and the newborn in humansD Thiébaud, S Janisch, H Koelbl, et al.
International Journal of Cancer|April 22, 1997
CD44 is an independent prognostic factor in early-stage cervical cancerP Speiser, C Wanner, C Tempfer, et al.
Anticancer Research|September 1, 1995
The influence of obesity on the disease-free survival in primary breast cancerA Obermair, C Kurz, E Hanzal, et al.
Anticancer Research|March 1, 1996
Influence of delayed diagnosis on established prognostic factors in endometrial cancerA Obermair, E Hanzal, I Schreiner-Frech, et al.
Pageof 6